Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300878 stock hub

SHE/300878 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/300878is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.5B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/300878
In the news

Latest news · SHE/300878

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/En/a
P25 23.5P50 41.3P75 83.2
ROE-20.9
P25 -0.9P50 4.1P75 8.8
ROIC-8.7
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/300878 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
191
Groups with data
11
Currency
CNY
Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
650
Employees Change
-509%
Employees Change Percent
-43.92
Enterprise value
CNY 4.6B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE1000047P9
Last refreshed
2026-05-10
Market cap
CNY 4.5B
Price
CNY 31.7
Price currency
CNY
Rev Per Employee
346,397.92x
Sector
Healthcare
Sic
2834
Symbol
she/300878
Website
https://www.zjwk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-4.79%
EV Earnings
-21.16x
EV/FCF
-2,808.72x
EV/Sales
20.27x
FCF yield
-0.04%
P/B ratio
4.87x
P/S ratio
20x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-29.46%
EBITDA Margin
-1.02%
Gross margin
33.56%
Gross Profit
CNY 75.6M
Gross Profit Growth
-47.81%
Gross Profit Growth3 Y
-39.33%
Gross Profit Growth5 Y
-31.12%
Net Income
CNY -215.7M
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-89.06%
Profit Margin
-95.82%
Profit Per Employee
CNY -331,914
ROA
-2.83
Roa5y
-0.94
ROCE
-6.22
ROE
-20.89
Roe5y
-4.64
ROIC
-8.67
Roic5y
-2.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr1y
114.74%
Cagr3y
10.95%
Cagr5y
6.22%
Div CAGR3
-36.24%
EPS Growth Quarters
1
EPS Growth Years
0
OCF Growth Q
199.27%
OCF Growth3 Y
-22.69%
OCF Growth5 Y
9.4%
Revenue Growth
-35.86x
Revenue Growth Quarters
1x
Revenue Growth Years
0x
Revenue Growth3 Y
-24.93x
Revenue Growth5 Y
-18.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
CNY 0.15
Assets
CNY 1.3B
Cash
CNY 191.9M
Current Assets
CNY 383.3M
Current Liabilities
CNY 185.4M
Debt
CNY 239.6M
Debt EBITDA
CNY 30.42
Debt Equity
CNY 0.26
Debt FCF
CNY -147
Equity
CNY 925.6M
Liabilities
CNY 361.9M
Long Term Assets
CNY 904.2M
Long Term Liabilities
CNY 176.5M
Net Cash
CNY -47.7M
Net Cash By Market Cap
CNY -1.06
Net Debt Equity
CNY 0.05
Tangible Book Value
CNY 882.2M
Tangible Book Value Per Share
CNY 6.07
WACC
6.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.95
Inventory Turnover
1.56
Net Working Capital
CNY 165.5M
Quick ratio
1.59
Working Capital
CNY 209.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

7
MetricValue
Buyback Yield
-1.17%
Dividend Growth
-44%
Dividend Growth Years
0%
Dividend per share
CNY 0.14
Dividend Years
2
Dividend Yield
0.44%
Last Dividend
CNY 0.14

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
114.63%
200-day SMA
25.56
3Y total return
36.6%
50-day SMA
28.06
50-day SMA vs 200-day SMA
50over200
5Y total return
35.22%
All Time High
61
All Time High Change
-48.03%
All Time High Date
2020-08-25
All Time Low
13.08
All Time Low Change
142.35%
All Time Low Date
2025-04-09
ATR
1.39
Beta
0.49
Beta1y
0.13
Beta2y
0.52
Ch YTD
24.27
High
32.55
High52
37.11
High52 Date
2026-01-12
High52ch
-14.58%
Low
30.5
Low52
14.71
Low52 Date
2025-05-12
Low52ch
115.5%
Ma50ch
12.96%
Price vs 200-day SMA
24.01%
RSI
70.73
RSI Monthly
66.01
RSI Weekly
59.27
Sharpe ratio
1.41x
Sortino ratio
2.81
Total Return
-0.73%
Tr YTD
24.27
Tr1m
14.19%
Tr1w
8.19%
Tr3m
14.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CNY -66.3M
Operating margin
-29.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
36,858,986%
Net Borrowing
-122,522,417
Shares Insiders
69.88%
Shares Institutions
0.39%
Shares Out
142,051,296
Shares Qo Q
0.05%
Shares Yo Y
1.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
CNY -1.6M
Average Volume
1,994,030x
Bv Per Share
6.28
CAPEX
CNY -54.3M
Ch1m
14.19
Ch1w
8.19
Ch1y
112.8
Ch3m
14.65
Ch3y
33.36
Ch5y
27.65
Ch6m
24.02
Change
2.76%
Change From Open
3.87
Close
30.85
Days Gap
-1.07
Depreciation Amortization
62,878,103
Dollar Volume
130,683,250
Earnings Date
2026-04-29
EBIT
CNY -66.3M
EBITDA
CNY -2.3M
EPS
CNY -1.49
F Score
3
FCF
CNY -1.6M
FCF EV Yield
-0.04x
FCF Per Share
CNY -0.01
Financing CF
-76,364,662
Fiscal Year End
December
Founded
2,000
Income Tax
CNY 17.6M
Investing CF
-64,897,336
Is Primary Listing
1
Last Earnings Date
2026-04-29
Last Report Date
2025-12-31
Last Split Date
2022-06-17
Last Split Type
Forward
Ma150
26.8
Ma150ch
18.31%
Ma20
27.51
Ma20ch
15.24%
Net CF
-88,580,927
Next Earnings Date
2026-08-28
Open
30.52
P OCF Ratio
85.48
Payment Date
2025-05-29
Position In Range
58.54
Ppne
759,091,681
Price Date
2026-05-08
Ptbv Ratio
5.1
Relative Volume
2.22x
Revenue
225,158,650x
Tax By Revenue
7.84x
Tr6m
24.02%
Volume
4,122,500
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/300878 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.4%
$0.14 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
-0.7%
Dividend yield + buyback yield combined
Performance

SHE/300878 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+114.6%
S&P 500 1Y: n/a
3Y total return
+36.6%
S&P 500 3Y: n/a
5Y total return
+35.2%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHE/300878?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.4%
Share of float held by funds and institutions
Insider ownership
+69.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.2%
Negative means the company is buying back shares.
Technical

SHE/300878 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
70.7
Above 70: short-term overbought
Price vs 200-day MA
+24.0%
50/200-day relationship not available
Beta (5Y)
0.49
Less volatile than the market
Sharpe ratio
1.41
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/300878

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300878 stock rating?

she/300878 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300878 analysis?

The full report lives at /stocks/she/300878/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300878?

The latest report frames she/300878 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300878 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

she/300878 stock profile: metrics, valuation and analysis | Agent IA du Marché Boursier